Pembrolizumab, Rezatapopt
Colorectal Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Non-small Cell Lung Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Prostate Cancer, Metastatic Solid Tumor, Advanced Solid Tumor, Triple Negative Breast Cancer, Small Cell Lung Cancer, Nsclc, Head And Neck Cancer, Metastatic Cancer, Small Cell Lung Carcinoma, Er/Pr Positive Breast Cancer, Nsclc (Non-Small Cell Lung Cancer), Sclc, Her2-Negative Breast Cancer, Her2-Positive Breast Cancer, Gall Bladder Cancer, Small Cell Lung Cancer ( Sclc ), Er/Pr(+), Her2(-) Breast Cancer, Advanced Malignant Neoplasm, Other Cancer, Locally Advanced, Tnbc, Her2+ Breast Cancer, Her2- Breast Cancer
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)